AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

StayHappi Gliclazide+Metformin 40mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Sarvagunaushdhi Pvt Ltd

Salt Composition

Gliclazide (40mg) + Metformin (500mg)

Overview StayHappi Gliclazide+Metformin 40mg/500mg Tablet

Diabetics using the combined medication Gliclazide/Metformin (40mg/500mg), such as the StayHappi brand, should understand it's an anti-diabetic drug treating type 2 diabetes in adults by regulating blood glucose. Administered with meals, consistent daily dosing maximizes effectiveness; dosage is personalized and adjusted based on blood sugar monitoring. Continuous use is crucial; abrupt cessation without medical guidance risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a holistic approach involving diet, exercise, and weight management as directed by your physician. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation and nausea may also occur. Maintaining regular meals and carrying a readily available glucose source (e.g., sugary snacks or juice) is vital. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Other possible side effects include altered taste, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is a possibility. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, along with periodic blood tests to assess blood cell counts and liver function.

Primary Ingredients of StayHappi Gliclazide+Metformin 40mg/500mg Tablet

No information provided. Please provide the text you wish to be rewritten.

Uses of StayHappi Gliclazide+Metformin 40mg/500mg Tablet

Diabetes mellitus, type 2

Major Benefits of StayHappi Gliclazide+Metformin 40mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the StayHappi Gliclazide+Metformin 40mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of StayHappi Gliclazide+Metformin 40mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use StayHappi Gliclazide+Metformin 40mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the StayHappi Gliclazide+Metformin 40mg/500mg tablet whole; do not chew, crush, or fracture it. Administer this medication with a meal.

How StayHappi Gliclazide+Metformin 40mg/500mg Tablet works:

StayHappi tablets, containing 40mg Gliclazide and 500mg Metformin, offer a dual-action approach to diabetes management by combining these two effective antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking StayHappi Gliclazide+Metformin 40mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using StayHappi Gliclazide+Metformin 40mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Exceptionally, a physician might prescribe it in critical circumstances where the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of StayHappi Gliclazide+Metformin 40mg/500mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use StayHappi Gliclazide+Metformin 40mg/500mg Tablets cautiously, potentially requiring dosage modification. Consultation with a physician is essential. This medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use StayHappi Gliclazide+Metformin 40mg/500mg Tablets cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, treatment typically begins with a low dose of StayHappi Gliclazide+Metformin 40mg/500mg Tablets; however, it's contraindicated in cases of severe liver disease.

What if you forget to take StayHappi Gliclazide+Metformin 40mg/500mg Tablet :

Should you forget a StayHappi Gliclazide+Metformin 40mg/500mg Tablet dose, administer it promptly. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About StayHappi Gliclazide+Metformin 40mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on StayHappi Gliclazide+Metformin 40mg/500mg Tablet

StayHappi Gliclazide+Metformin 40mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is unsuitable for type 1 diabetes.
StayHappi Gliclazide+Metformin 40mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
StayHappi Gliclazide+Metformin 40mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
StayHappi Gliclazide+Metformin 40mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in individuals with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue use and seek immediate medical attention.
Prolonged use of StayHappi Gliclazide+Metformin 40mg/500mg Tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems – ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
StayHappi Gliclazide+Metformin 40mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and those with moderate-to-severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining alcohol with StayHappi Gliclazide+Metformin 40mg/500mg tablets is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
StayHappi Gliclazide+Metformin 40mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
StayHappi Gliclazide+Metformin 40mg/500mg Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
StayHappi Gliclazide+Metformin 40mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
StayHappi Gliclazide+Metformin 40mg/500mg Tablets can cause lactic acidosis, a serious, potentially life-threatening condition (also known as Metformin-associated lactic acidosis, or MALA) resulting from excessive blood lactic acid. While rare, this risk is higher in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of StayHappi Gliclazide+Metformin 40mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
StayHappi Gliclazide+Metformin 40mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining alcohol with StayHappi Gliclazide+Metformin 40mg/500mg tablets is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
StayHappi Gliclazide+Metf...
26
MRP 30
13% off